Dutasteride Not Cost-Effective for PCa Prevention in Most Men - Renal and Urology News
Links shared publicly online about this topic.
- 518total visits
Dutasteride Not Cost-Effective for PCa Prevention in Most Men - Renal and Urology News
Dutasteride (Avodart) may only be a cost-effective means of preventing prostate cancer (PCa) in men at very high risk of the disease rather than all men at elevated risk, according to the results of a recent analysis.
View full resource at renalandurologynews.com
Tags: Kidney Health, Urinary System, Benign Prostatic Hypertrophy Medication, Men's Health, Avodart, Urology, News
Most Recently Shared on February 9, 2011 at 9:34 pm By:
Dutasteride Not Cost-Effective for PCa Prevention in Most Men: Dutasteride (Avodart) may only be a cost-effectiv... http://bit.ly/hwimqy
Advertisement
